ヒトパピローマウイルス(HPV)検査機器の世界市場

◆英語タイトル:Global HPV Testing Market 2015-2019
◆商品コード:IRTNTR6293
◆発行会社(リサーチ会社):Technavio
◆発行日:2015年6月17日
◆ページ数:65
◆レポート形式:英語 / pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、ヒトパピローマウイルス(HPV)検査機器の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、ヒトパピローマウイルス(HPV)検査機器の世界市場規模及び予測、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・ヒトパピローマウイルス(HPV)検査機器の世界市場:市場規模及び予測
・ヒトパピローマウイルス(HPV)検査機器の世界市場:地域別分析
・市場シェア
・購買基準
・市場成長要因
・市場の課題
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About HPV
HPV refers to a group of more than 200 related viruses commonly causing infections that do not have any symptoms. Among these, more than 40 types of HPV cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals undergo regular HPV tests as a preventive measure. HPV tests help detect the viral genetic material in a cell sample taken from the cervix.
Technavio’s analysts forecast the global HPV testing market to grow at a CAGR of 16.17% over the period 2014-2019.

[Covered in this Report]
This report covers the present and future scenarios of the global HPV testing market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of HPV testing kits and detection systems. The report includes the segmentation of the market based on the following three regions: the Americas, APAC, and EMEA.

Technavio’s report, Global HPV Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott Diagnostics
• Hologic
• Qiagen
• Roche Diagnostics

[Other Prominent Vendor]
• Arbor Vita
• Becton, Dickinson and Company
• Cepheid
• Delphi Bioscience
• DiaCarta
• Diasorin
• Fujirebio
• Genera Biosystems
• IncellDx
• OralDNA Labs
• Quest Diagnostics
• Seegene
• Trovagene
• Ventana Medical Systems

[Market Driver]
• Increased Incidence of HPV
• For a full, detailed list, view our report

[Market Challenge]
• Lack of Public Awareness
• For a full, detailed list, view our report

[Market Trend]
• Co-testing with HPV and Pap Tests
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 HPV Testing Market in US
06.3.1 Market Size and Forecast
06.4 Five Forces Analysis

07.HPV: An Overview
07.1 HPV Types
07.2 HPV and Cervical Cancer
07.2.1 Incidence and Prevalence
07.2.2 Symptoms
07.2.3 Diagnosis

08.Reimbursement and Coverage: An Overview

09.Geographical Segmentation
09.1 HPV Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 HPV Testing Market in EMEA
09.2.1 Market Size and Forecast
09.3 HPV Testing Market in APAC
09.3.1 Market Size and Forecast

10.Buying Criteria

11.Market Growth Drivers

12.Drivers and Their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and Their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.2 Market Share Analysis 2014
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Abbott Diagnostics
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Geographical Presence
18.1.4 SWOT Analysis
18.2 Hologic
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Sales by Geography
18.2.6 Business Strategy
18.2.7 Key Developments
18.2.8 SWOT Analysis
18.3 Qiagen
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Product Segmentation by Revenue 2013
18.3.4 Product Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Roche Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2014
18.4.4 Business Segmentation by Revenue 2013 and 2014
18.4.5 Geographical Segmentation by Revenue 2014
18.4.6 Business Strategy
18.4.7 Recent Developments
18.4.8 SWOT Analysis

19.Other Reports in This Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global HPV Testing Market 2014-2019 ($ millions)
Exhibit 3: HPV Testing Market in US 2014-2019 ($ millions)
Exhibit 4: Snapshot: Cervical Cancer
Exhibit 5: Reimbursement Perspectives of Healthcare Entities
Exhibit 6: Segmentation of Global HPV Testing Market by Geography 2014
Exhibit 7: HPV Testing Market in Americas 2014-2019 ($ millions)
Exhibit 8: HPV Testing Market in EMEA 2014-2019 ($ millions)
Exhibit 9: HPV Testing Market in APAC 2014-2019 ($ millions)
Exhibit 10: Segmentation of Global HPV Testing Market by Region 2014-2019
Exhibit 11: Global HPV Testing Market: YoY Growth Rate by Region 2014-2019
Exhibit 12: Abbott Diagnostics: Key Takeaways
Exhibit 13: Hologic: Key Takeaways
Exhibit 14: Qiagen: Key Takeaways
Exhibit 15: Roche Diagnostics: Key Takeaways
Exhibit 16: Abbott Diagnostics: Geographical Presence
Exhibit 17: Hologic: Revenue Segmentation 2013
Exhibit 18: Revenue Comparison FY2012 and FY2013 ($ millions)
Exhibit 19: Hologic: Sales by Geography 2013
Exhibit 20: Qiagen: Product Segmentation by Revenue 2013
Exhibit 21: Qiagen: Product Segmentation by Revenue 2012 and 2013 ($ millions)
Exhibit 22: Qiagen: Geographical Segmentation by Revenue 2013
Exhibit 23: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 24: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 25: Roche Diagnostics: Geographical Segmentation by Revenue 2014



【掲載企業】

Abbott Diagnostics, Hologic, Qiagen, Roche Diagnostics, Arbor Vita, Becton, Dickinson and Company, Cepheid, Delphi Bioscience, DiaCarta, Diasorin, Fujirebio, Genera Biosystems, IncellDx, OralDNA Labs, Quest Diagnostics, Seegene, Trovagene, Ventana Medical Systems

【レポートのキーワード】

ヒトパピローマウイルス、HPV検査機器、検査キット、医療

【リサーチ方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒトパピローマウイルス(HPV)検査機器の世界市場(Global HPV Testing Market 2015-2019)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆